GEN Edge - Latest

Latest

All

Cancer

Roche-Poseida Lead Allogeneic CAR-T Advances after Showing Promise in Multiple Myeloma

Genome Editing

Prime Medicine Inks Up-to-$3.5B Collaboration with BMS, Narrows Pipeline

OMICs

StockWatch: Turnaround Lifts GeneDx Stock 3,600%, with Profitability Near

Drug Discovery

Pfizer Withdraws SCD Drug Oxbryta after EMA Discloses 16 Deaths in Trials

Artificial Intelligence

Nvidia Launches AI Reference Workflow for Drug Discoverers

Artificial Intelligence

Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration

Drug Discovery

StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat

Industry News

Double Impact: Interest Rates and Prospects For Biotech Growth

Drug Discovery

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors

Drug Discovery

StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial

Drug Discovery

$600M+ Credit Firm Targets Life-Sci Companies in Later Stages

Artificial Intelligence

Recursion’s Ambitions: Developing 100+ Candidates, Joining with Exscientia

Drug Discovery

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration

Drug Discovery

Avak Kahvejian, PhD, Recounts His Journey from Sequencing Pioneer to Flagship General Partner on “Close to the Edge”

Artificial Intelligence

Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML

OMICs

Illumina and the State of the Genomics Market

Drug Discovery

StockWatch: Neurocrine Tumbles as Schizophrenia Data Disappoints

Cancer

Hold and Kill: Halda Raises $126M toward Precision Cancer Treatments

OMICs

StockWatch: Analysts Positive on Illumina’s New Strategy

Drug Discovery

StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk

Artificial Intelligence

Recursion to Acquire Exscientia, Combining AI Drug Pioneers

Artificial Intelligence

With $10M from Gates Foundation, Schrödinger Takes Aim at Toxicity Risk

Artificial Intelligence

Giving Structure to Language: Profluent’s AI Models Move toward Precise and Steerable Protein Design

Drug Discovery

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data

Drug Discovery

RNA Editing Therapy Developer Closes $60M Series A Financing

Drug Discovery

GSK, Flagship Launch Up-to-$7B+ Development Partnership

Drug Discovery

Lecanemab Approval for Early Alzheimer’s Disease Hits Roadblock in Europe

Drug Discovery

StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares

Artificial Intelligence

Flagship Pioneering Unveils Abiologics with Focus on “Supranatural” Biologics

Summits

The State of Biotech 2024